Diasorin Deutschland GmbH is a company based in Neu-Isenburg. It is registered in the commercial register of the Offenbach am Main local court under HRB 11889. The company was founded in 1994. In 2024, the company reported revenue of €99,667,319.
der Erwerb, die Herstellung (einschließlich Lohnherstellung), die Lagerung, die Bewerbung und der Vertrieb von in-vitro-Diagnostika einschließlich zugehöriger Analysengeräte und Laborchemikalien sowie der Erwerb und die Vergabe von Lizenzrechten für diese Produkte, die Anmeldung von Schutzrechten aller Art für diese Produkte sowie die Durchführung von Leistungsbewertungsprüfungen
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
Source: German Commercial Register (Handelsregister) Offenbach am Main Local Court, HRB 11889 (as of 1 November 2026)
| Name | Type | City |
|---|---|---|
| Thorsten Hilbich | Geschäftsführer(in) | Dreieich |
| Jan Marhoffer | Geschäftsführer(in) | Göttingen |
| Valerio Vaccarone | Geschäftsführer(in) | Novara |
Source: German Commercial Register (Handelsregister) Offenbach am Main Local Court, HRB 11889 (as of 1 November 2026)
| Date | Contract | Value |
|---|---|---|
| 8.5.2025 | Supplier · Klinikum der Stadt Ludwigshafen am Rhein gGmbH | — |
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | €99,667,319 | €4,141,532 | €60,051,989 | — |
| 2023 | €92,060,325 | €481,385 | €50,748,630 | — |
| 2022 | €92,890,913 | -€2,379,303 | €45,980,924 | — |
| 2021 | €83,211,854 | €1,955,523 | €41,212,657 | — |
| 2020 | €78,843,118 | €1,917,402 | €39,014,232 | — |
| 2019 | €80,408,457 | €4,116,823 | €39,326,278 | — |
| 2018 | €77,789,037 | €4,166,131 | €39,848,228 | — |
| 2017 | €69,109,223 | €3,045,621 | €38,008,534 | — |
| 2016 | €63,991,235 | €4,686,984 | €29,803,937 | — |
| 2015 | €56,419,826 | €3,140,083 | €29,992,955 | — |
Sign in to download data
Source: German Commercial Register (Handelsregister) Offenbach am Main Local Court, HRB 11889 (as of 1 November 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €18,742,636 | 84.0% |
| Depreciation | €3,008,728 | 13.5% |
| Interest & Similar | €565,626 | 2.5% |
